Why growth hormone matters
Growth hormone (GH) isn't just for growing taller. In adults, it's one of the most important regulatory hormones in the body. GH influences how you build and maintain muscle, how efficiently you metabolize fat, how well you sleep, how quickly you recover from exercise and injury, and even aspects of cognitive function and mood.
Starting in your late 20s, your pituitary gland begins producing less growth hormone. This decline — sometimes called somatopause — accelerates through your 30s, 40s, and beyond. By age 60, many adults produce only a fraction of the growth hormone they did at 25. The symptoms are often gradual and easy to dismiss: harder to lose fat, harder to build muscle, sleep isn't as restful, recovery takes longer, energy fades earlier in the day.
Peptide secretagogues offer a way to address this decline by stimulating your body's own growth hormone production — working with your natural biology rather than replacing it.
How GH secretagogues work
A secretagogue is any substance that causes another substance to be secreted. In this context, GH secretagogues are peptides that stimulate your pituitary gland to release more of your own growth hormone. This is fundamentally different from taking synthetic HGH (human growth hormone) injections.
With synthetic HGH, you're adding external growth hormone to your system. This bypasses your body's feedback mechanisms, can lead to supraphysiological levels, and carries risks including joint pain, fluid retention, insulin resistance, and potential tumor growth. HGH also requires careful dosing and monitoring.
With secretagogues, your pituitary gland is doing the work. Your body's natural regulatory systems remain intact — negative feedback loops prevent overproduction. The result is a more natural, pulsatile release pattern that more closely mimics youthful GH production. The risk profile is substantially lower than exogenous HGH.
Peptides used for hormone optimization
Sermorelin
Sermorelin is a GHRH (growth hormone-releasing hormone) analog consisting of the first 29 amino acids of natural GHRH. It stimulates the pituitary gland to produce and release growth hormone in its natural pulsatile pattern. Sermorelin has been used clinically for decades — it was originally FDA-approved as a diagnostic tool for GH deficiency in children, and it has an extensive safety record.
Sermorelin is typically administered as a subcutaneous injection before bedtime, capitalizing on the body's natural nocturnal GH secretion pattern. Many patients notice improved sleep quality within the first few weeks — deeper, more restorative sleep is one of the most consistently reported early benefits.
Regulatory status: Sermorelin is a Category 1 peptide, meaning it is legally compoundable by licensed US pharmacies. It has the strongest regulatory standing of any GH secretagogue currently available.
CJC-1295 / Ipamorelin
CJC-1295 is a modified GHRH analog with a longer half-life than Sermorelin, meaning it provides more sustained GH stimulation. Ipamorelin is a growth hormone-releasing peptide (GHRP) that stimulates GH release through a different receptor pathway (the ghrelin receptor). When combined, they provide a more robust and comprehensive GH release signal.
The CJC-1295/Ipamorelin combination has been popular in clinical practice because it tends to produce a stronger GH response than either peptide alone. Ipamorelin is also notable for being one of the most selective GHRPs — it increases GH without significantly affecting cortisol, prolactin, or other hormones, which gives it a cleaner side effect profile than older GHRPs.
Regulatory status: CJC-1295 and Ipamorelin are currently classified as Category 2 peptides by the FDA. Compounding is currently restricted pending potential reclassification. Availability depends on ongoing regulatory review. If these peptides are unavailable at the time of your consultation, your physician will discuss alternative options, including Sermorelin-based protocols.
Benefits of optimized growth hormone
- Sleep: GH is released primarily during deep (N3) sleep. Secretagogues help restore this nocturnal pattern, leading to more restorative sleep. This is often the first benefit patients notice and arguably the most important, since sleep quality affects virtually every aspect of health.
- Recovery: Improved GH levels support protein synthesis and tissue repair. Patients frequently report faster recovery from workouts, fewer aches and pains, and improved exercise tolerance.
- Body composition: Growth hormone plays a direct role in lipolysis (fat breakdown) and supports lean muscle maintenance. Over months of treatment, many patients see modest but meaningful improvements in body fat distribution and muscle tone, particularly when combined with regular exercise.
- Energy: The combination of better sleep, improved recovery, and enhanced metabolic function often translates to noticeably better daily energy levels. This isn't a stimulant effect — it's your body functioning more efficiently.
- Skin and appearance: GH influences collagen production and skin cell turnover. Some patients report improvements in skin thickness, elasticity, and hydration over several months of treatment.
Who this is for
Hormone optimization through peptide secretagogues is appropriate for adults — typically over 30 — who are experiencing symptoms consistent with age-related GH decline. These symptoms include:
- Persistent fatigue not explained by other conditions
- Poor sleep quality despite good sleep hygiene
- Difficulty maintaining muscle mass or losing body fat
- Slow recovery from exercise or injury
- General sense of reduced vitality
It's important to note that these symptoms can have many causes. Your physician will evaluate whether your symptoms are consistent with suboptimal GH levels and whether secretagogue therapy is the right approach, rather than attributing everything to growth hormone.
What labs are needed
Before starting a GH secretagogue protocol, your physician will typically order blood work to establish a baseline and rule out other conditions. Common labs include:
- IGF-1 (Insulin-like Growth Factor 1): The primary biomarker for growth hormone status. IGF-1 levels provide a more reliable picture than direct GH measurement because GH is released in pulses throughout the day.
- Complete metabolic panel: To assess liver function, kidney function, and blood sugar levels.
- Thyroid panel: Thyroid dysfunction can mimic many symptoms of GH decline.
- Fasting insulin and glucose: GH affects insulin sensitivity, so baseline metabolic status is important.
- Lipid panel: To establish cardiovascular risk baseline.
Follow-up labs are typically checked at 3 months and periodically thereafter to monitor your response and adjust dosing.
What to expect
Frequently asked questions
Will GH secretagogues show up on a drug test?
Standard workplace drug tests do not test for peptides or growth hormone. However, competitive athletes subject to WADA or USADA testing should be aware that GH secretagogues are prohibited in competition. If you compete in tested sports, discuss this with your physician before starting treatment.
Can GH secretagogues cause cancer?
This is a common concern that deserves a careful answer. Growth hormone does not cause cancer. However, GH can promote the growth of cells generally — including potentially pre-existing cancer cells. This is why your physician will screen for cancer risk factors before prescribing. The pulsatile, physiological GH levels produced by secretagogues (as opposed to the supraphysiological levels possible with HGH injection) are generally considered lower risk. If you have a personal history of cancer, your physician will carefully evaluate the risk-benefit profile.
What's the difference between Sermorelin and CJC-1295/Ipamorelin?
Both stimulate GH production, but through slightly different mechanisms and timelines. Sermorelin has a shorter half-life and produces a more natural, acute GH pulse — most similar to your body's native pattern. CJC-1295 has a longer half-life, providing more sustained GH elevation. Ipamorelin works through the ghrelin receptor rather than the GHRH receptor. The combination of CJC-1295/Ipamorelin tends to produce a stronger overall GH response. Your physician will recommend the appropriate option based on your goals, lab values, and regulatory availability.
Interested in growth hormone optimization?
Request Sermorelin or other GH secretagogues during your assessment. Your physician will review your labs and determine the right protocol.